Letter: ciclosporin or infliximab in acute ulcerative colitis - still undecided; authors' reply

被引：0
|
作者：
Croft, A. [1 ]
Walsh, A. [2 ]
Doecke, J. [3 ,4 ,5 ]
Radford-Smith, G. [1 ,6 ,7 ]
机构：
[1] Royal Brisbane & Womens Hosp, Dept Gastroenterol, Brisbane, Qld, Australia
[2] St Vincents Hosp, Dept Gastroenterol, Sydney, NSW 2010, Australia
[3] Royal Brisbane & Womens Hosp, Australian E Hlth Res Ctr, Brisbane, Qld, Australia
[4] CSIRO Preventat Hlth Flagship, Melbourne, Vic, Australia
[5] Macquarie Univ, CSIRO Math & Informat Sci, Sydney, NSW 2109, Australia
[6] Queensland Inst Med Res, IBD Grp, Brisbane, Qld 4006, Australia
[7] Univ Queensland, Sch Med, Brisbane, Qld, Australia
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2013年 / 38卷 / 08期
关键词：
D O I：
10.1111/apt.12474
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：993 / 993
页数：1
相关论文
共 50 条
  • [21] Steroid-refractory ulcerative colitis-ciclosporin or infliximab?
    Kaur, Manreet
    Targan, Stephen R.
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2013, 10 (01) : 8 - 9
  • [22] Infliximab and refractory ulcerative colitis Reply
    Ferrante, Marc
    Vermeire, Severine
    Van Assche, Gert
    Rutgeerts, Paul
    JOURNAL OF CROHNS & COLITIS, 2009, 3 (01): : 45 - 45
  • [23] Letter: Should ulcerative colitis be monitored more or less invasively? Authors' reply
    Lenfant, Matthias
    Verstockt, Bram
    Sabino, Joao
    Vermeire, Severine
    Ferrante, Marc
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (05) : 723 - 724
  • [24] Letter: ulcerative colitis in patients transplanted for primary sclerosing cholangitis - authors' reply
    Navaneethan, U.
    Venkatesh, P. G. K.
    Kiran, R. P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (03) : 297 - 297
  • [25] Letter: comparative efficacy of biological therapy in patients with ulcerative colitis - authors' reply
    Stidham, R. W.
    Lee, T. C. H.
    Higgins, P. D. R.
    Deshpande, A. R.
    Sussman, D. A.
    Singal, A. G.
    Elmunzer, B. J.
    Vijan, S.
    Saini, S. D.
    Waljee, A. K.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (12) : 1433 - 1434
  • [26] Appendicectomy and ulcerative colitis - Authors' reply
    Cosnes, J
    Carbonnel, F
    Beaugerie, L
    Gendre, JP
    GUT, 2003, 52 (05) : 768 - 769
  • [27] Letter: how can we reduce mortality in elderly patients with acute severe ulcerative colitis? Authors' reply
    Dong, Catherine
    Metzger, Marie
    Holsbo, Einar E.
    Perduca, Vittorio
    Carbonnel, Franck
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (12) : 1445 - 1446
  • [28] Letter: factors that may predict response to ciclosporin in ulcerative colitis
    Farkas, K.
    Balint, A.
    Nagy, F.
    Szepes, Z.
    Szucs, M.
    Wittmann, T.
    Molnar, T.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (06) : 654 - 654
  • [29] Infliximab or cyclosporine for severe ulcerative colitis - Reply
    D'Haens, G
    GASTROENTEROLOGY, 2005, 129 (04) : 1359 - 1359
  • [30] Letter: ciclosporin and vedolizumab for steroid-refractory ulcerative colitis
    Resal, Tamas
    Pigniczki, Daniella
    Szanto, Kata
    Rutka, Mariann
    Farkas, Klaudia
    Molnar, Tamas
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (03) : 578 - 579
12345